Fuda Cancer Hospital
Thyroid cancer treatment cost in China runs from $6,800 to $13,200 for a primary thyroidectomy, while radioactive iodine therapy typically ranges from $3,500 to $7,500. Total expenses depend on the surgical approach, hospital classification, and cancer stage. Patients can expect 40-70% savings compared to the United States. Top medical hubs for oncology include Beijing and Guangzhou.
Typical Thyroid Cancer Treatment Costs in China
Bookimed Expert Insight: Advanced stage patients find the best value at specialized oncology centers like Fuda Cancer Hospital. They offer minimally invasive cryosurgery and NanoKnife technologies for complex cases. For international patients seeking premium care, Yanda International Hospital provides JCI-accredited Class A Level III services. Dr. Niu Lizhi is a recommended choice for patients requiring expert surgical oncology with over 10,000 procedures performed.
| China | Turkey | Austria | |
| Thyroidectomy | from $6,800 | from $2,000 | from $9,000 |
| Thyroid resection | from $8,200 | from $2,050 | from $10,000 |
| Subtotal thyroidectomy | from $7,500 | from $3,500 | from $9,000 |
| Radioiodine therapy | from $3,500 | from $1,200 | from $3,000 |
| Radiation therapy for colorectal cancer | from $11,500 | from $7,000 | from $12,000 |
Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.
Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.
Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.
Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.
He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.
Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.
He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).
Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).
He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.
Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.
Standard thyroid cancer treatments in China follow international protocols, including thyroidectomy, radioiodine therapy, and targeted medications. Facilities like Fuda Cancer Hospital and Yanda International Hospital provide JCI-accredited care. These centers utilize advanced diagnostics like PET/CT and biopsy to align with global oncology standards.
Bookimed Expert Insight: China's top-tier hospitals demonstrate a high degree of specialization in minimally invasive technology. For instance, Dr. Niu Lizhi at Fuda Cancer Hospital has performed over 10,000 cryosurgeries. This massive clinical volume at Class A Level III clinics often leads to refined techniques in nerve-sparing surgery that helps preserve the patient's voice.
Patient Consensus: Patients note that care in major cities like Beijing or Shanghai strictly follows global guidelines. They often suggest seeking private wings or international departments to navigate language barriers and ensure access to English-speaking specialists.
Surgeons in major Chinese centers like Fuda Cancer Hospital are highly experienced due to massive patient volumes. Over 3,000 inpatient thyroid surgeries occur annually at top-tier institutions. Senior specialists often possess JCI-accredited training. Modern techniques like robotic-assisted surgery are widely available in Shanghai and Beijing.
Bookimed Expert Insight: Data shows a major gap between surgical skill and administrative communication. While Fuda Cancer Hospital serves patients from 100+ countries, nurses and anesthesiologists may have minimal English. Yanda International Hospital manages 2,500,000 patients yearly, making high-volume efficiency their priority. Choosing a clinic with JCI accreditation ensures that international safety protocols are met regardless of language barriers.
Patient Consensus: Patients note that while surgeons are technically excellent, relying on translation apps for consent forms is risky. They recommend hiring a professional medical translator to avoid confusion regarding post-operative medication and drain management instructions.
Recovery after thyroid surgery in China includes 1 to 3 days of hospitalization. Patients typically return to daily habits within 2 weeks. Follow-up care features lifelong surveillance. International hospitals like Fuda Cancer Hospital use minimally invasive techniques to accelerate healing and reduce neck scarring.
Bookimed Expert Insight: Chinese oncology centers often blend high-tech diagnostics with traditional supportive care. Major institutions like Yanda International Hospital hold Class A Level III status, the highest tier in China. This ensures access to advanced imaging like PET/CT scans every 3 months for early detection. Meanwhile, specialists may integrate acupuncture to manage swelling and stiffness. This hybrid approach allows clinics like Fuda to treat over 30,000 international patients effectively.
Patient Consensus: Patients note that voice changes usually resolve within 2 weeks. Many recommend having calcium supplements ready at home to manage early post-operative tingling or low-calcium symptoms.
Chinese JCI-accredited oncology centers offer minimally invasive thyroid procedures. These techniques relocate incisions to hidden areas like the lower lip or armpit. Surgeons use internal sutures and medical glue to ensure no visible marks remain on the neck. Recovery typically occurs within 2 weeks.
Bookimed Expert Insight: Chinese healthcare tiers heavily influence technology access. Class A Level III facilities like Yanda International Hospital offer over 28,000 modern technologies. This high concentration of equipment allows surgeons at major centers to perform complex procedures through a single hidden incision. This provides a measurable aesthetic advantage over standard multi-port approaches.
Patient Consensus: Patients note that scarless refers to the neck specifically. Small marks in the armpit or mouth are common. Many suggest using silicone gel sheets for the first 6 months to ensure the best cosmetic result.
Patients can undergo initial evaluations for thyroid cancer in China through remote video consultations or digital record reviews. Required documentation includes recent thyroid function tests, high-resolution neck ultrasounds, and contrast-enhanced CT scans. Centers like Fuda Cancer Hospital utilize these digital files to coordinate preliminary surgical planning before international travel.
Bookimed Expert Insight: Yanda International Hospital and other JCI-accredited centers in China maintain a Class A Level III status. This highest tier of certification ensures they handle massive patient volumes while following international safety protocols. Data shows these institutions often require repeat imaging on-site even if high-quality foreign scans are provided. This internal validation is a standard safety measure for precise surgical mapping.
Patient Consensus: Patients note it is essential to ship physical pathology slides ahead of time to avoid delays. Having medical reports professionally translated into Chinese significantly speeds up the remote approval process.
Chinese hospitals ensure safety for international thyroid cancer patients through Joint Commission International (JCI) accreditation and rigorous national protocols. Top-tier facilities utilize multidisciplinary teams and standardized clinical guidelines. These centers combine advanced surgical technology with specialized international medical departments to maintain high treatment quality.
Bookimed Expert Insight: While many search for general prestige, high-volume specialty centers often provide superior surgical safety. Dr. Niu Lizhi at Fuda Cancer Hospital has performed over 10,000 cryosurgeries. This high volume across 100+ countries signals deep expertise in complex cases that general hospitals might not match. Choosing a clinic with a 4.6 rating like Fuda ensures both technological variety and proven international experience.
Patient Consensus: Patients note that safety is reliable at major centers, but a private interpreter is often necessary. Many emphasize using WeChat for coordination as English communication within hospitals can be limited to scripted phrases.
Guangzhou, Beijing, and Shanghai feature the most comprehensive thyroid cancer centers. These hubs offer Joint Commission International-accredited facilities. Eligible citizens from 50+ countries enjoy 30-day visa-free entry. Others utilizing 144-hour transit exemptions can access specialized care in these three major cities without a full visa.
Bookimed Expert Insight: Guangzhou presents a unique advantage for non-surgical thyroid care. While many centers focus on resection, Fuda Cancer Hospital specializes in cryosurgery and microwave ablation. Dr. Niu Lizhi has performed nearly 10,000 cryosurgeries. This focus on minimally invasive technology provides a vital alternative for patients seeking options beyond traditional thyroidectomy.
Patient Consensus: Patients note that combining surgery and radioactive iodine in one trip is most efficient in Shanghai. They also advise using support services for logistics instead of traveling solo.